Provincial Respiratory Syncytial Virus Prophylaxis Program Update

Public Health Alert

To: Ottawa Physicians and Nurse Practitioners

Date: April 10, 2025

From: Dr. Laura Bourns, Deputy Medical Officer of Health

Subject: Provincial Respiratory Syncytial Virus Prophylaxis Program Update

Dear Colleagues,

Please see this memo from Ontario’s Chief Medical Officer of Health on Ontario’s 2025 Respiratory Syncytial Virus (RSV) program.

Key Messages:

  • The 2024-2025 infant and high-risk children RSV prevention program has ended.
  • Doses of Beyfortus and Abrysvo should no longer be ordered or administered to infants, children, or pregnant individuals.
  • Please keep all remaining non-expired Beyfortus and Abrysvo product inventory refrigerated in your office under appropriate cold chain for use next season.
Back to News Search

Welcome to the new OttawaPublicHealth.ca

Ottawa Public Health has moved to a refreshed website. During this transition, some links, redirects, documents, pages or display features may be temporarily affected.

Your feedback will help us review and address issues during the stabilization period.